Why the study?
Should age alone be used as a criterion to limit the use of PTCA in elderly CAD patients?
Should age alone be used as a criterion to limit the use of PTCA in elderly CAD patients?
Advanced age alone should not preclude the use of PTCA in patients with coronary artery disease.
May support PTCA in elderly CAD without age limits; leaves open randomized confirmation before practice change.
While advanced age is associated with changes in risk and clinical parameters for CAD patients, age alone is not a reasonable criterion to limit the use of PTCA.
No takes yet. Share an insight, caveat, or question.
Forman et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: